(Q38010349)

26 August 2017

title

Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance (English)

1 reference

26 August 2017

1 reference

1 reference

acute myeloid leukemia

1 reference

Van Thanh Hoang

1

1 reference

26 August 2017

Abraham Zepeda-Moreno

series ordinal

2

1 reference

26 August 2017

Anthony D Ho

series ordinal

3

1 reference

26 August 2017

publication date

16 May 2012

1 reference

26 August 2017

published in

Biotechnology Journal

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

779-788

1 reference

26 August 2017

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

New approaches for the detection of minimal residual disease in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Hematopoiesis: a human perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Stem cell gene expression programs influence clinical outcome in human leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Genetic variegation of clonal architecture and propagating cells in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

ABCG2 -- a transporter for all seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The role of human aldehyde dehydrogenase in normal and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Differential survival of AML subpopulations in NOD/SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Signaling pathways governing stem-cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Hox genes in hematopoiesis and leukemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

NF-κB addiction and its role in cancer: 'one size does not fit all'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Disrupting the stem cell niche: good seeds in bad soil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Osteoblastic cells regulate the haematopoietic stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The vascular niche: home for normal and malignant hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Aging of hematopoietic stem cells is regulated by the stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Leukemia stem cells and microenvironment: biology and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

CXCR4 is a prognostic marker in acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Angiogenesis in acute myeloid leukemia and opportunities for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The hemangioblast: cradle to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Leukemia regression by vascular disruption and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell−cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100350

21 January 2018

Identifiers

DOI

10.1002/BIOT.201100350

1 reference

26 August 2017

1 reference